Literature DB >> 26048886

In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain.

Shigeru Tajima1, Kazumi Yagasaki1, Akira Kotaki1, Takumi Tomikawa1, Eri Nakayama1, Meng Ling Moi1, Chang-Kweng Lim1, Masayuki Saijo1, Ichiro Kurane1, Tomohiko Takasaki1.   

Abstract

The characteristics of genotype V Japanese encephalitis virus (GV JEV) remain poorly understood as only two strains have been isolated to date. In this study, we examined the effects of the GV JEV Muar strain on in vitro growth and pathogenicity in mice; we also evaluated the efficacy of inactivated JEV vaccines against the Muar strain. Although growth of the Muar strain in mouse neuroblastoma N18 cells was clearly worse than that of the GIII Beijing-1 and GI Mie/41/2002 strains, neuroinvasiveness of the Muar strain was similar to that of the Beijing-1 strain and significantly higher than that of the Mie/41/2002 strain. The results of a plaque reduction neutralization test suggested that the neutralization ability of the JEV vaccines against the Muar strain was reduced compared with the GI and GIII strains. However, the protection potency of the JEV vaccine against the Muar strain was similar to that for the Beijing-1 strain in mice. Our data indicate that GV JEV has unique growth, virulence and antigenicity features.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26048886     DOI: 10.1099/vir.0.000213

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

Review 1.  Evolving Epidemiology of Japanese Encephalitis: Implications for Vaccination.

Authors:  John P Caldwell; Lin H Chen; Davidson H Hamer
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

2.  European Aedes albopictus and Culex pipiens Are Competent Vectors for Japanese Encephalitis Virus.

Authors:  Mélissanne de Wispelaere; Philippe Desprès; Valérie Choumet
Journal:  PLoS Negl Trop Dis       Date:  2017-01-13

3.  Amino Acid at Position 166 of NS2A in Japanese Encephalitis Virus (JEV) is Associated with In Vitro Growth Characteristics of JEV.

Authors:  Shigeru Tajima; Satoshi Taniguchi; Eri Nakayama; Takahiro Maeki; Takuya Inagaki; Chang-Kweng Lim; Masayuki Saijo
Journal:  Viruses       Date:  2020-06-30       Impact factor: 5.048

Review 4.  How Central Is the Domestic Pig in the Epidemiological Cycle of Japanese Encephalitis Virus? A Review of Scientific Evidence and Implications for Disease Control.

Authors:  Héléna Ladreyt; Benoit Durand; Philippe Dussart; Véronique Chevalier
Journal:  Viruses       Date:  2019-10-15       Impact factor: 5.048

5.  Evaluating the competence of the primary vector, Culex tritaeniorhynchus, and the invasive mosquito species, Aedes japonicus japonicus, in transmitting three Japanese encephalitis virus genotypes.

Authors:  Astri Nur Faizah; Daisuke Kobayashi; Michael Amoa-Bosompem; Yukiko Higa; Yoshio Tsuda; Kentaro Itokawa; Kozue Miura; Kazuhiro Hirayama; Kyoko Sawabe; Haruhiko Isawa
Journal:  PLoS Negl Trop Dis       Date:  2020-12-28

6.  Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.

Authors:  Lei Cao; Shihong Fu; Xiaoyan Gao; Minghua Li; Shiheng Cui; Xiaolong Li; Yuxi Cao; Wenwen Lei; Zhi Lu; Ying He; Huanyu Wang; Jinghua Yan; George Fu Gao; Guodong Liang
Journal:  PLoS Negl Trop Dis       Date:  2016-05-03

7.  Effects of the Japanese Encephalitis Virus Genotype V-Derived Sub-Viral Particles on the Immunogenicity of the Vaccine Characterized by a Novel Virus-Like Particle-Based Assay.

Authors:  Sarah Honjo; Michiaki Masuda; Tomohiro Ishikawa
Journal:  Vaccines (Basel)       Date:  2019-08-04

8.  E and prM proteins of genotype V Japanese encephalitis virus are required for its increased virulence in mice.

Authors:  Shigeru Tajima; Ken-Ichi Shibasaki; Satoshi Taniguchi; Eri Nakayama; Takahiro Maeki; Chang-Kweng Lim; Masayuki Saijo
Journal:  Heliyon       Date:  2019-11-23

9.  West Nile virus capsid protein inhibits autophagy by AMP-activated protein kinase degradation in neurological disease development.

Authors:  Shintaro Kobayashi; Kentaro Yoshii; Wallaya Phongphaew; Memi Muto; Minato Hirano; Yasuko Orba; Hirofumi Sawa; Hiroaki Kariwa
Journal:  PLoS Pathog       Date:  2020-01-23       Impact factor: 6.823

10.  Embryonic Stage of Congenital Zika Virus Infection Determines Fetal and Postnatal Outcomes in Mice.

Authors:  Eri Nakayama; Yasuhiro Kawai; Satoshi Taniguchi; Jessamine E Hazlewood; Ken-Ichi Shibasaki; Kenta Takahashi; Yuko Sato; Bing Tang; Kexin Yan; Naoko Katsuta; Shigeru Tajima; Chang Kweng Lim; Tadaki Suzuki; Andreas Suhrbier; Masayuki Saijo
Journal:  Viruses       Date:  2021-09-11       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.